Arax Advisory Partners
ACHV icon

Arax Advisory Partners’s Achieve Life Sciences ACHV Stock Holding History

Arax Advisory Partners’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65 Buy
10
+9
+900% +$43 ﹤0.01% 5153
2026
Q1 		$29 Sell
1
-9
-90% -$40 ﹤0.01% 3693
2025
Q4 		$50 Hold
10
– – ﹤0.01% 3913
2025
Q3 		$31 Buy
+10
New +$27 ﹤0.01% 3556

Other funds holding ACHV

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TPG GP A
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Arax Advisory Partners's ACHV Position: Q2 2026 in Review

Arax Advisory Partners increased its Achieve Life Sciences (ACHV) stake by 900% in Q2 2026, buying an estimated $43 and bringing the position to 10 shares worth $65. The position accounts for ﹤0.01% of the portfolio, ranked #5153.

Arax Advisory Partners first reported a position in ACHV in Q3 2025 and has held it in 4 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Arax Advisory Partners held 10 shares of Achieve Life Sciences worth $65 as of Q2 2026.
  • Arax Advisory Partners bought 9 Achieve Life Sciences shares in Q2 2026, an estimated $43.
  • Achieve Life Sciences made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #5153 holding.
  • Arax Advisory Partners first reported a position in Achieve Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.